Header cover image
  • Investing Ideas
  • Chinese Pharmaceuticals & Biotech Large Cap High Growth Potential

Chinese Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

1

1 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

WuXi AppTec

Market Cap: CN¥331.4b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

New

603259

CN¥109.55

7D

9.5%

1Y

85.1%